Cannabis Science Conference Spring 2024: Interview with Cultivation Program Chair Zacariah Hildenbrand, PhD
In this 2-minute interview, Program Chair Zacariah Hildenbrand shares insights into the upcoming Cannabis Science Conference Spring 2024.
Taking place May 7–9, 2024, in Kansas City, Missouri, Cannabis Science Conference is the premier cannabis science conference focusing on analytical science, medical cannabis, cultivation, and compliance. Heading our Cultivation Program is Zacariah Hildenbrand, PhD. Dr. Hildenbrand is a research Professor at the University of Texas at El Paso, the principal founder of Inform Environmental, a partner of Medusa Analytical, and is a director of the Curtis Mathes Corporation (OTC:CMCZ). He is also a regular contributor to Cannabis Science and Technology’s Cultivation Classroom column.
Get a sneak peek into the Cultivation Track with the video below, and register here for Cannabis Science Conference Spring 2024!
Read the transcript below:
What are some new topics in cannabis cultivation?
Zacariah Hildenbrand: Well, when it comes to cannabis or hemp cultivation, obviously, a lot of folks are interested in hop latent viroid. Some of these other pathogens, the testing associated thereof. Testing, I would just say testing in general, whether you're looking at pests or pathogens, or you're looking at potency numbers, I think a lot of people are very much concerned with the state of analytical testing in the field right now. And I happen to be one of them. You're going to see a lot of questions, comments, a lot of discussion at the forthcoming Cannabis Science Conference about testing in particular.
What are some topics being covered in the Cultivation Track?
Hildenbrand: We're going to cover all of the genetic factors that are associated with providing highly efficacious flower materials, so high THC, high CBD, ancillary cannabinoids, we're going to touch on the terpenes, the various classes of flavonoids, the carotenoids, the anthocyanins. As I mentioned before, we're going to talk about pests and pathogen management. We'll talk about air, soil, water quality, and of course, lighting. Then we're going to have a number of talks, looking kind of at some of the new analytical tools that are coming out, qPCR some of these new techniques that have kind of infiltrated into the cannabis realm.
What are you most looking forward to learning at the conference?
Hildenbrand: Ah, just in general, I mean, all of the times that I've gone to this conference have been a fantastic experience, because it's highly collaborative. I get to interact with folks. They're very personable and they're very accessible. And it really leads to the formation of new collaborations on the research front. I think it's a fantastic arena for people to come and establish new business partnerships. It's just way more accessible than anything you're going to see out there. And so I just think it's the quality of the interactions that you have at Cannabis Science Conference that makes it unique.
Cannabis, US Presidential Election 2024, and Beyond: A Roundtable Discussion, Part II
December 17th 2024With the recent 2024 presidential election behind us, the future of cannabis still has many unknowns moving forward and questions still to be discussed. In this roundtable discussion with four knowledgeable industry leaders, we explore the nuanced political landscape of cannabis legalization and rescheduling in the context of the election, including state and federal policies and possible paths forward for testing standardization. Join us in the second part of a compilation of responses from Kim Anzarut, CQA, CP-FS, CEO of Allay Consulting; Susan Audino, PhD, founder of S.A. Audino & Associates, LLC; Zacariah Hildenbrand, PhD, research Professor at the University of Texas at El Paso; and David Vaillencourt, CEO of The GMP Collective.
Cannabis, US Presidential Election 2024, and Beyond: A Roundtable Discussion, Part I
December 16th 2024With the recent 2024 presidential election behind us, the future of cannabis still has many unknowns moving forward and questions still to be discussed. In this roundtable discussion with four knowledgeable industry leaders, we explore the nuanced political landscape of cannabis legalization and rescheduling in the context of the election. We discuss what drives support or opposition from both sides of the aisle, the complexities of balancing state and federal priorities, and more. Join us in the first part of a compilation of responses from Kim Anzarut, CQA, CP-FS, CEO of Allay Consulting; Susan Audino, PhD, founder of S.A. Audino & Associates, LLC; Zacariah Hildenbrand, PhD, research Professor at the University of Texas at El Paso; and David Vaillencourt, CEO of The GMP Collective.
Empowering Women in Cannabis: Susan Audino, PhD, on Inclusivity, Integrity, and Industry Challenges
December 11th 2024Founder of S. A. Audino & Associates, LLC, Susan Audino, PhD, recently co-founded Saturn Scientific, LLC, a collaboration of five experienced individuals providing unbiased evaluations on the data and science for stakeholders in the cannabis industry. In this interview with Cannabis Science and Technology, Dr. Audino shares her unexpected path into analytical science and the cannabis industry as well as the obstacles she’s faced throughout her career. She highlights the gender bias she’s observed, such as unequal recognition of credentials and workplace challenges, while advocating for inclusivity and mentorship to empower women in science. Additionally, Dr. Audino recounts her experiences of navigating the male-dominated cannabis space, pushing for transparency, collaboration, and integrity in laboratory practices. Ultimately, Audino believes fostering mutual respect and knowledge-sharing is vital for the industry’s growth and resilience.
Collaboration, Gender Diversity, and Progress: Julie Kowalski on Advancing Cannabis Science
December 10th 2024In this interview with Cannabis Science and Technology, Julie Kowalski, an experienced analytical chemist, discusses her path into the cannabis industry, starting with early work in gas chromatography. Kowalski reflects on her perspectives as a female scientist, highlighting biases she’s experienced and the benefits of gender inclusivity in the cannabis space. Greater unity and professionalism could benefit the industry as a whole, she explains. She also encourages collaboration and more women in leadership positions in order to build a stronger scientific community, and also urges women to advocate for themselves, noting that women in cannabis face unique obstacles but often demonstrate consensus-building strategies and solutions.
